nodes	percent_of_prediction	percent_of_DWPC	metapath
Delavirdine—CYP3A7—Ifosfamide—testicular cancer	0.101	0.146	CbGbCtD
Delavirdine—CYP3A7-CYP3A51P—Ifosfamide—testicular cancer	0.101	0.146	CbGbCtD
Delavirdine—CYP3A5—Ifosfamide—testicular cancer	0.0755	0.109	CbGbCtD
Delavirdine—CYP2C8—Ifosfamide—testicular cancer	0.0726	0.105	CbGbCtD
Delavirdine—CYP2C19—Ifosfamide—testicular cancer	0.0609	0.0881	CbGbCtD
Delavirdine—CYP2C9—Ifosfamide—testicular cancer	0.0506	0.0732	CbGbCtD
Delavirdine—CYP3A5—Etoposide—testicular cancer	0.0361	0.0522	CbGbCtD
Delavirdine—CYP2C8—Etoposide—testicular cancer	0.0347	0.0502	CbGbCtD
Delavirdine—CYP3A4—Ifosfamide—testicular cancer	0.0294	0.0426	CbGbCtD
Delavirdine—CYP1A2—Etoposide—testicular cancer	0.0269	0.0388	CbGbCtD
Delavirdine—CYP2C9—Cisplatin—testicular cancer	0.0246	0.0356	CbGbCtD
Delavirdine—CYP2D6—Vinblastine—testicular cancer	0.0246	0.0355	CbGbCtD
Delavirdine—CYP3A4—Vinblastine—testicular cancer	0.0156	0.0226	CbGbCtD
Delavirdine—CYP2D6—Doxorubicin—testicular cancer	0.0151	0.0218	CbGbCtD
Delavirdine—CYP3A4—Etoposide—testicular cancer	0.0141	0.0203	CbGbCtD
Delavirdine—CYP3A4—Doxorubicin—testicular cancer	0.0096	0.0139	CbGbCtD
Delavirdine—Fatigue—Etoposide—testicular cancer	0.000177	0.000573	CcSEcCtD
Delavirdine—Neuropathy peripheral—Epirubicin—testicular cancer	0.000176	0.000572	CcSEcCtD
Delavirdine—Jaundice—Epirubicin—testicular cancer	0.000175	0.000569	CcSEcCtD
Delavirdine—Stomatitis—Epirubicin—testicular cancer	0.000175	0.000569	CcSEcCtD
Delavirdine—Constipation—Etoposide—testicular cancer	0.000175	0.000568	CcSEcCtD
Delavirdine—Pain—Etoposide—testicular cancer	0.000175	0.000568	CcSEcCtD
Delavirdine—Urinary tract infection—Epirubicin—testicular cancer	0.000175	0.000567	CcSEcCtD
Delavirdine—Conjunctivitis—Epirubicin—testicular cancer	0.000175	0.000567	CcSEcCtD
Delavirdine—Neutropenia—Doxorubicin—testicular cancer	0.000175	0.000566	CcSEcCtD
Delavirdine—Upper respiratory tract infection—Doxorubicin—testicular cancer	0.000174	0.000563	CcSEcCtD
Delavirdine—Hepatitis—Methotrexate—testicular cancer	0.000173	0.00056	CcSEcCtD
Delavirdine—Haematuria—Epirubicin—testicular cancer	0.000172	0.000557	CcSEcCtD
Delavirdine—Dizziness—Ifosfamide—testicular cancer	0.000172	0.000556	CcSEcCtD
Delavirdine—Pharyngitis—Methotrexate—testicular cancer	0.000171	0.000556	CcSEcCtD
Delavirdine—Weight increased—Doxorubicin—testicular cancer	0.00017	0.000551	CcSEcCtD
Delavirdine—Epistaxis—Epirubicin—testicular cancer	0.00017	0.000551	CcSEcCtD
Delavirdine—Sinusitis—Epirubicin—testicular cancer	0.000169	0.000548	CcSEcCtD
Delavirdine—Feeling abnormal—Etoposide—testicular cancer	0.000169	0.000547	CcSEcCtD
Delavirdine—Hyperglycaemia—Doxorubicin—testicular cancer	0.000169	0.000546	CcSEcCtD
Delavirdine—Nausea—Dactinomycin—testicular cancer	0.000168	0.000545	CcSEcCtD
Delavirdine—Pneumonia—Doxorubicin—testicular cancer	0.000168	0.000543	CcSEcCtD
Delavirdine—Gastrointestinal pain—Etoposide—testicular cancer	0.000168	0.000543	CcSEcCtD
Delavirdine—Stevens-Johnson syndrome—Doxorubicin—testicular cancer	0.000165	0.000535	CcSEcCtD
Delavirdine—Vomiting—Ifosfamide—testicular cancer	0.000165	0.000535	CcSEcCtD
Delavirdine—Hypersensitivity—Cisplatin—testicular cancer	0.000165	0.000534	CcSEcCtD
Delavirdine—Bradycardia—Epirubicin—testicular cancer	0.000165	0.000533	CcSEcCtD
Delavirdine—Rash—Ifosfamide—testicular cancer	0.000164	0.00053	CcSEcCtD
Delavirdine—Dermatitis—Ifosfamide—testicular cancer	0.000163	0.00053	CcSEcCtD
Delavirdine—Erythema multiforme—Methotrexate—testicular cancer	0.000163	0.000529	CcSEcCtD
Delavirdine—Neuropathy peripheral—Doxorubicin—testicular cancer	0.000163	0.000529	CcSEcCtD
Delavirdine—Urticaria—Etoposide—testicular cancer	0.000163	0.000528	CcSEcCtD
Delavirdine—Jaundice—Doxorubicin—testicular cancer	0.000162	0.000526	CcSEcCtD
Delavirdine—Stomatitis—Doxorubicin—testicular cancer	0.000162	0.000526	CcSEcCtD
Delavirdine—Rhinitis—Epirubicin—testicular cancer	0.000162	0.000525	CcSEcCtD
Delavirdine—Abdominal pain—Etoposide—testicular cancer	0.000162	0.000525	CcSEcCtD
Delavirdine—Body temperature increased—Etoposide—testicular cancer	0.000162	0.000525	CcSEcCtD
Delavirdine—Urinary tract infection—Doxorubicin—testicular cancer	0.000162	0.000525	CcSEcCtD
Delavirdine—Conjunctivitis—Doxorubicin—testicular cancer	0.000162	0.000525	CcSEcCtD
Delavirdine—Hepatitis—Epirubicin—testicular cancer	0.000162	0.000524	CcSEcCtD
Delavirdine—Tinnitus—Methotrexate—testicular cancer	0.000161	0.000522	CcSEcCtD
Delavirdine—Hypoaesthesia—Epirubicin—testicular cancer	0.000161	0.000521	CcSEcCtD
Delavirdine—Asthenia—Cisplatin—testicular cancer	0.00016	0.00052	CcSEcCtD
Delavirdine—Pharyngitis—Epirubicin—testicular cancer	0.00016	0.00052	CcSEcCtD
Delavirdine—Oedema peripheral—Epirubicin—testicular cancer	0.000159	0.000516	CcSEcCtD
Delavirdine—Haematuria—Doxorubicin—testicular cancer	0.000159	0.000515	CcSEcCtD
Delavirdine—Epistaxis—Doxorubicin—testicular cancer	0.000157	0.000509	CcSEcCtD
Delavirdine—Sinusitis—Doxorubicin—testicular cancer	0.000156	0.000507	CcSEcCtD
Delavirdine—Chills—Methotrexate—testicular cancer	0.000155	0.000502	CcSEcCtD
Delavirdine—Nausea—Ifosfamide—testicular cancer	0.000154	0.0005	CcSEcCtD
Delavirdine—Diarrhoea—Cisplatin—testicular cancer	0.000153	0.000496	CcSEcCtD
Delavirdine—Erythema multiforme—Epirubicin—testicular cancer	0.000153	0.000495	CcSEcCtD
Delavirdine—Alopecia—Methotrexate—testicular cancer	0.000153	0.000495	CcSEcCtD
Delavirdine—Bradycardia—Doxorubicin—testicular cancer	0.000152	0.000494	CcSEcCtD
Delavirdine—Hypersensitivity—Etoposide—testicular cancer	0.000151	0.000489	CcSEcCtD
Delavirdine—Tinnitus—Epirubicin—testicular cancer	0.000151	0.000489	CcSEcCtD
Delavirdine—Erythema—Methotrexate—testicular cancer	0.00015	0.000487	CcSEcCtD
Delavirdine—Malnutrition—Methotrexate—testicular cancer	0.00015	0.000487	CcSEcCtD
Delavirdine—Rhinitis—Doxorubicin—testicular cancer	0.00015	0.000486	CcSEcCtD
Delavirdine—Hepatitis—Doxorubicin—testicular cancer	0.00015	0.000485	CcSEcCtD
Delavirdine—Hypoaesthesia—Doxorubicin—testicular cancer	0.000149	0.000482	CcSEcCtD
Delavirdine—Pharyngitis—Doxorubicin—testicular cancer	0.000148	0.000481	CcSEcCtD
Delavirdine—Oedema peripheral—Doxorubicin—testicular cancer	0.000147	0.000478	CcSEcCtD
Delavirdine—Dysgeusia—Methotrexate—testicular cancer	0.000147	0.000477	CcSEcCtD
Delavirdine—Asthenia—Etoposide—testicular cancer	0.000147	0.000477	CcSEcCtD
Delavirdine—Back pain—Methotrexate—testicular cancer	0.000145	0.000472	CcSEcCtD
Delavirdine—Chills—Epirubicin—testicular cancer	0.000145	0.00047	CcSEcCtD
Delavirdine—Pruritus—Etoposide—testicular cancer	0.000145	0.00047	CcSEcCtD
Delavirdine—Alopecia—Epirubicin—testicular cancer	0.000143	0.000463	CcSEcCtD
Delavirdine—Vomiting—Cisplatin—testicular cancer	0.000142	0.000461	CcSEcCtD
Delavirdine—Vision blurred—Methotrexate—testicular cancer	0.000142	0.000459	CcSEcCtD
Delavirdine—Erythema multiforme—Doxorubicin—testicular cancer	0.000141	0.000458	CcSEcCtD
Delavirdine—Rash—Cisplatin—testicular cancer	0.000141	0.000457	CcSEcCtD
Delavirdine—Dermatitis—Cisplatin—testicular cancer	0.000141	0.000457	CcSEcCtD
Delavirdine—Erythema—Epirubicin—testicular cancer	0.000141	0.000456	CcSEcCtD
Delavirdine—Malnutrition—Epirubicin—testicular cancer	0.000141	0.000456	CcSEcCtD
Delavirdine—Diarrhoea—Etoposide—testicular cancer	0.00014	0.000454	CcSEcCtD
Delavirdine—Ill-defined disorder—Methotrexate—testicular cancer	0.000139	0.000452	CcSEcCtD
Delavirdine—Tinnitus—Doxorubicin—testicular cancer	0.000139	0.000452	CcSEcCtD
Delavirdine—Anaemia—Methotrexate—testicular cancer	0.000139	0.000451	CcSEcCtD
Delavirdine—Flatulence—Epirubicin—testicular cancer	0.000139	0.00045	CcSEcCtD
Delavirdine—Tension—Epirubicin—testicular cancer	0.000138	0.000448	CcSEcCtD
Delavirdine—Dysgeusia—Epirubicin—testicular cancer	0.000138	0.000447	CcSEcCtD
Delavirdine—Nervousness—Epirubicin—testicular cancer	0.000137	0.000443	CcSEcCtD
Delavirdine—Back pain—Epirubicin—testicular cancer	0.000136	0.000441	CcSEcCtD
Delavirdine—Malaise—Methotrexate—testicular cancer	0.000136	0.00044	CcSEcCtD
Delavirdine—Dizziness—Etoposide—testicular cancer	0.000135	0.000439	CcSEcCtD
Delavirdine—Muscle spasms—Epirubicin—testicular cancer	0.000135	0.000439	CcSEcCtD
Delavirdine—Vertigo—Methotrexate—testicular cancer	0.000135	0.000438	CcSEcCtD
Delavirdine—Leukopenia—Methotrexate—testicular cancer	0.000135	0.000436	CcSEcCtD
Delavirdine—Chills—Doxorubicin—testicular cancer	0.000134	0.000435	CcSEcCtD
Delavirdine—Nausea—Cisplatin—testicular cancer	0.000133	0.000431	CcSEcCtD
Delavirdine—Vision blurred—Epirubicin—testicular cancer	0.000133	0.00043	CcSEcCtD
Delavirdine—Alopecia—Doxorubicin—testicular cancer	0.000132	0.000428	CcSEcCtD
Delavirdine—Cough—Methotrexate—testicular cancer	0.000131	0.000425	CcSEcCtD
Delavirdine—Ill-defined disorder—Epirubicin—testicular cancer	0.000131	0.000423	CcSEcCtD
Delavirdine—Vomiting—Etoposide—testicular cancer	0.00013	0.000422	CcSEcCtD
Delavirdine—Erythema—Doxorubicin—testicular cancer	0.00013	0.000422	CcSEcCtD
Delavirdine—Malnutrition—Doxorubicin—testicular cancer	0.00013	0.000422	CcSEcCtD
Delavirdine—Anaemia—Epirubicin—testicular cancer	0.00013	0.000422	CcSEcCtD
Delavirdine—Agitation—Epirubicin—testicular cancer	0.000129	0.000419	CcSEcCtD
Delavirdine—Rash—Etoposide—testicular cancer	0.000129	0.000419	CcSEcCtD
Delavirdine—Dermatitis—Etoposide—testicular cancer	0.000129	0.000418	CcSEcCtD
Delavirdine—Headache—Etoposide—testicular cancer	0.000128	0.000416	CcSEcCtD
Delavirdine—Flatulence—Doxorubicin—testicular cancer	0.000128	0.000416	CcSEcCtD
Delavirdine—Chest pain—Methotrexate—testicular cancer	0.000128	0.000415	CcSEcCtD
Delavirdine—Myalgia—Methotrexate—testicular cancer	0.000128	0.000415	CcSEcCtD
Delavirdine—Arthralgia—Methotrexate—testicular cancer	0.000128	0.000415	CcSEcCtD
Delavirdine—Tension—Doxorubicin—testicular cancer	0.000128	0.000414	CcSEcCtD
Delavirdine—Dysgeusia—Doxorubicin—testicular cancer	0.000127	0.000413	CcSEcCtD
Delavirdine—Malaise—Epirubicin—testicular cancer	0.000127	0.000411	CcSEcCtD
Delavirdine—Discomfort—Methotrexate—testicular cancer	0.000126	0.00041	CcSEcCtD
Delavirdine—Nervousness—Doxorubicin—testicular cancer	0.000126	0.00041	CcSEcCtD
Delavirdine—Vertigo—Epirubicin—testicular cancer	0.000126	0.00041	CcSEcCtD
Delavirdine—Syncope—Epirubicin—testicular cancer	0.000126	0.000409	CcSEcCtD
Delavirdine—Leukopenia—Epirubicin—testicular cancer	0.000126	0.000408	CcSEcCtD
Delavirdine—Back pain—Doxorubicin—testicular cancer	0.000126	0.000408	CcSEcCtD
Delavirdine—Muscle spasms—Doxorubicin—testicular cancer	0.000125	0.000406	CcSEcCtD
Delavirdine—Palpitations—Epirubicin—testicular cancer	0.000124	0.000403	CcSEcCtD
Delavirdine—Confusional state—Methotrexate—testicular cancer	0.000124	0.000401	CcSEcCtD
Delavirdine—Loss of consciousness—Epirubicin—testicular cancer	0.000124	0.000401	CcSEcCtD
Delavirdine—Cough—Epirubicin—testicular cancer	0.000123	0.000398	CcSEcCtD
Delavirdine—Vision blurred—Doxorubicin—testicular cancer	0.000123	0.000398	CcSEcCtD
Delavirdine—Infection—Methotrexate—testicular cancer	0.000122	0.000395	CcSEcCtD
Delavirdine—Nausea—Etoposide—testicular cancer	0.000122	0.000395	CcSEcCtD
Delavirdine—Hypertension—Epirubicin—testicular cancer	0.000121	0.000394	CcSEcCtD
Delavirdine—Ill-defined disorder—Doxorubicin—testicular cancer	0.000121	0.000392	CcSEcCtD
Delavirdine—Anaemia—Doxorubicin—testicular cancer	0.00012	0.00039	CcSEcCtD
Delavirdine—Thrombocytopenia—Methotrexate—testicular cancer	0.00012	0.00039	CcSEcCtD
Delavirdine—Myalgia—Epirubicin—testicular cancer	0.00012	0.000388	CcSEcCtD
Delavirdine—Chest pain—Epirubicin—testicular cancer	0.00012	0.000388	CcSEcCtD
Delavirdine—Arthralgia—Epirubicin—testicular cancer	0.00012	0.000388	CcSEcCtD
Delavirdine—Agitation—Doxorubicin—testicular cancer	0.00012	0.000388	CcSEcCtD
Delavirdine—Anxiety—Epirubicin—testicular cancer	0.000119	0.000387	CcSEcCtD
Delavirdine—Skin disorder—Methotrexate—testicular cancer	0.000119	0.000386	CcSEcCtD
Delavirdine—Hyperhidrosis—Methotrexate—testicular cancer	0.000119	0.000385	CcSEcCtD
Delavirdine—Discomfort—Epirubicin—testicular cancer	0.000118	0.000384	CcSEcCtD
Delavirdine—Malaise—Doxorubicin—testicular cancer	0.000117	0.000381	CcSEcCtD
Delavirdine—Dry mouth—Epirubicin—testicular cancer	0.000117	0.00038	CcSEcCtD
Delavirdine—Vertigo—Doxorubicin—testicular cancer	0.000117	0.000379	CcSEcCtD
Delavirdine—Anorexia—Methotrexate—testicular cancer	0.000117	0.000379	CcSEcCtD
Delavirdine—Syncope—Doxorubicin—testicular cancer	0.000117	0.000379	CcSEcCtD
Delavirdine—Leukopenia—Doxorubicin—testicular cancer	0.000117	0.000378	CcSEcCtD
Delavirdine—Confusional state—Epirubicin—testicular cancer	0.000116	0.000375	CcSEcCtD
Delavirdine—Palpitations—Doxorubicin—testicular cancer	0.000115	0.000373	CcSEcCtD
Delavirdine—Oedema—Epirubicin—testicular cancer	0.000115	0.000372	CcSEcCtD
Delavirdine—Hypotension—Methotrexate—testicular cancer	0.000115	0.000372	CcSEcCtD
Delavirdine—Loss of consciousness—Doxorubicin—testicular cancer	0.000114	0.000371	CcSEcCtD
Delavirdine—Infection—Epirubicin—testicular cancer	0.000114	0.00037	CcSEcCtD
Delavirdine—Cough—Doxorubicin—testicular cancer	0.000114	0.000368	CcSEcCtD
Delavirdine—Shock—Epirubicin—testicular cancer	0.000113	0.000366	CcSEcCtD
Delavirdine—Thrombocytopenia—Epirubicin—testicular cancer	0.000112	0.000365	CcSEcCtD
Delavirdine—Hypertension—Doxorubicin—testicular cancer	0.000112	0.000364	CcSEcCtD
Delavirdine—Tachycardia—Epirubicin—testicular cancer	0.000112	0.000363	CcSEcCtD
Delavirdine—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000112	0.000362	CcSEcCtD
Delavirdine—Skin disorder—Epirubicin—testicular cancer	0.000112	0.000362	CcSEcCtD
Delavirdine—Hyperhidrosis—Epirubicin—testicular cancer	0.000111	0.00036	CcSEcCtD
Delavirdine—Insomnia—Methotrexate—testicular cancer	0.000111	0.00036	CcSEcCtD
Delavirdine—Arthralgia—Doxorubicin—testicular cancer	0.000111	0.000359	CcSEcCtD
Delavirdine—Chest pain—Doxorubicin—testicular cancer	0.000111	0.000359	CcSEcCtD
Delavirdine—Myalgia—Doxorubicin—testicular cancer	0.000111	0.000359	CcSEcCtD
Delavirdine—Anxiety—Doxorubicin—testicular cancer	0.00011	0.000358	CcSEcCtD
Delavirdine—Paraesthesia—Methotrexate—testicular cancer	0.00011	0.000357	CcSEcCtD
Delavirdine—Discomfort—Doxorubicin—testicular cancer	0.00011	0.000355	CcSEcCtD
Delavirdine—Anorexia—Epirubicin—testicular cancer	0.000109	0.000355	CcSEcCtD
Delavirdine—Dyspnoea—Methotrexate—testicular cancer	0.000109	0.000355	CcSEcCtD
Delavirdine—Somnolence—Methotrexate—testicular cancer	0.000109	0.000354	CcSEcCtD
Delavirdine—Dry mouth—Doxorubicin—testicular cancer	0.000108	0.000351	CcSEcCtD
Delavirdine—Dyspepsia—Methotrexate—testicular cancer	0.000108	0.00035	CcSEcCtD
Delavirdine—Hypotension—Epirubicin—testicular cancer	0.000107	0.000348	CcSEcCtD
Delavirdine—Confusional state—Doxorubicin—testicular cancer	0.000107	0.000347	CcSEcCtD
Delavirdine—Decreased appetite—Methotrexate—testicular cancer	0.000107	0.000346	CcSEcCtD
Delavirdine—Oedema—Doxorubicin—testicular cancer	0.000106	0.000344	CcSEcCtD
Delavirdine—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000106	0.000343	CcSEcCtD
Delavirdine—Fatigue—Methotrexate—testicular cancer	0.000106	0.000343	CcSEcCtD
Delavirdine—Infection—Doxorubicin—testicular cancer	0.000106	0.000342	CcSEcCtD
Delavirdine—Pain—Methotrexate—testicular cancer	0.000105	0.00034	CcSEcCtD
Delavirdine—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000105	0.000339	CcSEcCtD
Delavirdine—Shock—Doxorubicin—testicular cancer	0.000105	0.000339	CcSEcCtD
Delavirdine—Thrombocytopenia—Doxorubicin—testicular cancer	0.000104	0.000337	CcSEcCtD
Delavirdine—Insomnia—Epirubicin—testicular cancer	0.000104	0.000337	CcSEcCtD
Delavirdine—Tachycardia—Doxorubicin—testicular cancer	0.000104	0.000336	CcSEcCtD
Delavirdine—Skin disorder—Doxorubicin—testicular cancer	0.000103	0.000335	CcSEcCtD
Delavirdine—Paraesthesia—Epirubicin—testicular cancer	0.000103	0.000334	CcSEcCtD
Delavirdine—Hyperhidrosis—Doxorubicin—testicular cancer	0.000103	0.000333	CcSEcCtD
Delavirdine—Dyspnoea—Epirubicin—testicular cancer	0.000102	0.000332	CcSEcCtD
Delavirdine—Somnolence—Epirubicin—testicular cancer	0.000102	0.000331	CcSEcCtD
Delavirdine—Anorexia—Doxorubicin—testicular cancer	0.000101	0.000328	CcSEcCtD
Delavirdine—Feeling abnormal—Methotrexate—testicular cancer	0.000101	0.000328	CcSEcCtD
Delavirdine—Dyspepsia—Epirubicin—testicular cancer	0.000101	0.000328	CcSEcCtD
Delavirdine—Gastrointestinal pain—Methotrexate—testicular cancer	0.0001	0.000325	CcSEcCtD
Delavirdine—Decreased appetite—Epirubicin—testicular cancer	9.98e-05	0.000324	CcSEcCtD
Delavirdine—Hypotension—Doxorubicin—testicular cancer	9.93e-05	0.000322	CcSEcCtD
Delavirdine—Gastrointestinal disorder—Epirubicin—testicular cancer	9.91e-05	0.000321	CcSEcCtD
Delavirdine—Fatigue—Epirubicin—testicular cancer	9.9e-05	0.000321	CcSEcCtD
Delavirdine—Pain—Epirubicin—testicular cancer	9.82e-05	0.000318	CcSEcCtD
Delavirdine—Constipation—Epirubicin—testicular cancer	9.82e-05	0.000318	CcSEcCtD
Delavirdine—Urticaria—Methotrexate—testicular cancer	9.75e-05	0.000316	CcSEcCtD
Delavirdine—Body temperature increased—Methotrexate—testicular cancer	9.7e-05	0.000314	CcSEcCtD
Delavirdine—Abdominal pain—Methotrexate—testicular cancer	9.7e-05	0.000314	CcSEcCtD
Delavirdine—Musculoskeletal discomfort—Doxorubicin—testicular cancer	9.68e-05	0.000314	CcSEcCtD
Delavirdine—Insomnia—Doxorubicin—testicular cancer	9.61e-05	0.000312	CcSEcCtD
Delavirdine—Paraesthesia—Doxorubicin—testicular cancer	9.54e-05	0.000309	CcSEcCtD
Delavirdine—Dyspnoea—Doxorubicin—testicular cancer	9.47e-05	0.000307	CcSEcCtD
Delavirdine—Feeling abnormal—Epirubicin—testicular cancer	9.46e-05	0.000307	CcSEcCtD
Delavirdine—Somnolence—Doxorubicin—testicular cancer	9.45e-05	0.000306	CcSEcCtD
Delavirdine—Gastrointestinal pain—Epirubicin—testicular cancer	9.39e-05	0.000304	CcSEcCtD
Delavirdine—Dyspepsia—Doxorubicin—testicular cancer	9.35e-05	0.000303	CcSEcCtD
Delavirdine—Decreased appetite—Doxorubicin—testicular cancer	9.24e-05	0.000299	CcSEcCtD
Delavirdine—Gastrointestinal disorder—Doxorubicin—testicular cancer	9.17e-05	0.000297	CcSEcCtD
Delavirdine—Fatigue—Doxorubicin—testicular cancer	9.16e-05	0.000297	CcSEcCtD
Delavirdine—Urticaria—Epirubicin—testicular cancer	9.12e-05	0.000296	CcSEcCtD
Delavirdine—Pain—Doxorubicin—testicular cancer	9.09e-05	0.000295	CcSEcCtD
Delavirdine—Constipation—Doxorubicin—testicular cancer	9.09e-05	0.000295	CcSEcCtD
Delavirdine—Body temperature increased—Epirubicin—testicular cancer	9.08e-05	0.000294	CcSEcCtD
Delavirdine—Abdominal pain—Epirubicin—testicular cancer	9.08e-05	0.000294	CcSEcCtD
Delavirdine—Hypersensitivity—Methotrexate—testicular cancer	9.04e-05	0.000293	CcSEcCtD
Delavirdine—Asthenia—Methotrexate—testicular cancer	8.8e-05	0.000285	CcSEcCtD
Delavirdine—Feeling abnormal—Doxorubicin—testicular cancer	8.76e-05	0.000284	CcSEcCtD
Delavirdine—Gastrointestinal pain—Doxorubicin—testicular cancer	8.69e-05	0.000282	CcSEcCtD
Delavirdine—Pruritus—Methotrexate—testicular cancer	8.68e-05	0.000281	CcSEcCtD
Delavirdine—Hypersensitivity—Epirubicin—testicular cancer	8.46e-05	0.000274	CcSEcCtD
Delavirdine—Urticaria—Doxorubicin—testicular cancer	8.44e-05	0.000274	CcSEcCtD
Delavirdine—Body temperature increased—Doxorubicin—testicular cancer	8.4e-05	0.000272	CcSEcCtD
Delavirdine—Abdominal pain—Doxorubicin—testicular cancer	8.4e-05	0.000272	CcSEcCtD
Delavirdine—Diarrhoea—Methotrexate—testicular cancer	8.4e-05	0.000272	CcSEcCtD
Delavirdine—Asthenia—Epirubicin—testicular cancer	8.24e-05	0.000267	CcSEcCtD
Delavirdine—Pruritus—Epirubicin—testicular cancer	8.12e-05	0.000263	CcSEcCtD
Delavirdine—Dizziness—Methotrexate—testicular cancer	8.11e-05	0.000263	CcSEcCtD
Delavirdine—Diarrhoea—Epirubicin—testicular cancer	7.86e-05	0.000255	CcSEcCtD
Delavirdine—Hypersensitivity—Doxorubicin—testicular cancer	7.83e-05	0.000254	CcSEcCtD
Delavirdine—Vomiting—Methotrexate—testicular cancer	7.8e-05	0.000253	CcSEcCtD
Delavirdine—Rash—Methotrexate—testicular cancer	7.74e-05	0.000251	CcSEcCtD
Delavirdine—Dermatitis—Methotrexate—testicular cancer	7.73e-05	0.000251	CcSEcCtD
Delavirdine—Headache—Methotrexate—testicular cancer	7.69e-05	0.000249	CcSEcCtD
Delavirdine—Asthenia—Doxorubicin—testicular cancer	7.62e-05	0.000247	CcSEcCtD
Delavirdine—Dizziness—Epirubicin—testicular cancer	7.59e-05	0.000246	CcSEcCtD
Delavirdine—Pruritus—Doxorubicin—testicular cancer	7.52e-05	0.000244	CcSEcCtD
Delavirdine—Vomiting—Epirubicin—testicular cancer	7.3e-05	0.000237	CcSEcCtD
Delavirdine—Nausea—Methotrexate—testicular cancer	7.29e-05	0.000236	CcSEcCtD
Delavirdine—Diarrhoea—Doxorubicin—testicular cancer	7.27e-05	0.000236	CcSEcCtD
Delavirdine—Rash—Epirubicin—testicular cancer	7.24e-05	0.000235	CcSEcCtD
Delavirdine—Dermatitis—Epirubicin—testicular cancer	7.23e-05	0.000235	CcSEcCtD
Delavirdine—Headache—Epirubicin—testicular cancer	7.19e-05	0.000233	CcSEcCtD
Delavirdine—Dizziness—Doxorubicin—testicular cancer	7.03e-05	0.000228	CcSEcCtD
Delavirdine—Nausea—Epirubicin—testicular cancer	6.82e-05	0.000221	CcSEcCtD
Delavirdine—Vomiting—Doxorubicin—testicular cancer	6.76e-05	0.000219	CcSEcCtD
Delavirdine—Rash—Doxorubicin—testicular cancer	6.7e-05	0.000217	CcSEcCtD
Delavirdine—Dermatitis—Doxorubicin—testicular cancer	6.69e-05	0.000217	CcSEcCtD
Delavirdine—Headache—Doxorubicin—testicular cancer	6.66e-05	0.000216	CcSEcCtD
Delavirdine—Nausea—Doxorubicin—testicular cancer	6.31e-05	0.000205	CcSEcCtD
